Firas Mourtada

TitleProfessor
InstitutionThomas Jefferson University
DepartmentRadiation Oncology
Address111 S. 11th Street
Philadelphia PA 19107
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Grover S, Lichter KE, Likhacheva A, Jang JW, Ning MS, Robin TP, Small W, Kudchadker RJ, Swamidas J, Chopra S, Rai B, Sharma SD, Sharma DN, Kuppusamy T, Yang R, Berger D, Mendez LC, Glaser S, Erickson DL, Chino J, Mourtada F, Abdel-Wahab M, Jhingran A, Simonds H, Mahantshetty U. The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries. Brachytherapy. 2023 Sep 11. PMID: 37704540.
      Citations:    
    2. Mourtada F, Tomiyoshi K, Sims-Mourtada J, Mukai-Sasaki Y, Yagihashi T, Namiki Y, Murai T, Yang DJ, Inoue T. Actinium-225 Targeted Agents: Where Are We Now? Brachytherapy. 2023 Sep 08. PMID: 37690972.
      Citations:    
    3. Maduro Bustos LA, Sarkar A, Doyle LA, Andreou K, Noonan J, Nurbagandova D, Shah SA, Irabor OC, Mourtada F. Feasibility evaluation of novel AI-based deep-learning contouring algorithm for radiotherapy. J Appl Clin Med Phys. 2023 Jul 18; e14090. PMID: 37464581.
      Citations:    
    4. Beaulieu L, Ballester F, Granero D, Tedgren ?C, Haworth A, Lowenstein JR, Ma Y, Mourtada F, Papagiannis P, Rivard MJ, Siebert FA, Sloboda RS, Smith RL, Thomson RM, Verhaegen F, Fonseca G, Vijande J. AAPM?WGDCAB Report 372:?A joint AAPM, ESTRO, ABG, and ABS report on?commissioning of model-based dose calculation algorithms in brachytherapy. Med Phys. 2023 Jul 10. PMID: 37427750.
      Citations:    
    5. Peppa V, Thomson RM, Enger SA, Fonseca GP, Lee C, Lucero JNE, Mourtada F, Siebert FA, Vijande J, Papagiannis P. A MC-based anthropomorphic test case for commissioning model-based dose calculation in interstitial breast 192-Ir HDR brachytherapy. Med Phys. 2023 May 17. PMID: 37194638.
      Citations:    
    6. Prisciandaro J, Zoberi JE, Cohen G, Kim Y, Johnson P, Paulson E, Song W, Hwang KP, Erickson B, Beriwal S, Kirisits C, Mourtada F. Erratum: "AAPM task group report 303 endorsed by the ABS: MRI implementation in HDR brachytherapy-Considerations from simulation to treatment" https://doi.org/10.1002/mp.15713. Med Phys. 2023 Feb; 50(2):1258. PMID: 36316956.
      Citations:    
    7. Harkenrider MM, Abu-Rustum N, Albuquerque K, Bradfield L, Bradley K, Dolinar E, Doll CM, Elshaikh M, Frick MA, Gehrig PA, Han K, Hathout L, Jones E, Klopp A, Mourtada F, Suneja G, Wright AA, Yashar C, Erickson BA. Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice Guideline. Pract Radiat Oncol. 2023 Jan-Feb; 13(1):41-65. PMID: 36280107.
      Citations:    
    8. Prisciandaro J, Zoberi JE, Cohen G, Kim Y, Johnson P, Paulson E, Song W, Hwang KP, Erickson B, Beriwal S, Kirisits C, Mourtada F. AAPM task group report 303 endorsed by the ABS: MRI implementation in HDR brachytherapy-Considerations from simulation to treatment. Med Phys. 2022 Aug; 49(8):e983-e1023. PMID: 35662032.
      Citations:    
    9. Sharma NK, Kappadath SC, Chuong M, Folkert M, Gibbs P, Jabbour SK, Jeyarajah DR, Kennedy A, Liu D, Meyer JE, Mikell J, Patel RS, Yang G, Mourtada F. The American Brachytherapy Society consensus statement for permanent implant brachytherapy using Yttrium-90 microsphere radioembolization for liver tumors. Brachytherapy. 2022 Sep-Oct; 21(5):569-591. PMID: 35599080.
      Citations:    
    10. Nguyen AT, Kim S, Keyes M, Petereit DG, Mourtada F, Rossi PJ, Klopp AH, Kamrava M. Evaluation of burnout in physician members of the American Brachytherapy Society. Brachytherapy. 2022 May-Jun; 21(3):362-368. PMID: 35249823.
      Citations:    
    11. Shah C, Vicini F, Beriwal S, Thaker N, Frank SJ, Rossi P, Orio P, Chang AJ, Joshi N, Campbell SR, Naghavi A, Chao S, Kamrava M, Deufel CL, Mourtada F, Suh JH. American Brachytherapy Society radiation oncology alternative payment model task force: Quality measures and metrics for brachytherapy. Brachytherapy. 2022 Jan-Feb; 21(1):63-74. PMID: 34732290.
      Citations:    
    12. Harkenrider MM, Albuquerque K, Brown D, Kamrava M, King M, Mourtada F, Orio P, Patel R, Price M, Rassiah P, Solanki AA, Small W, Schechter NR. ACR-ABS-ASTRO practice parameter for the performance of radionuclide-based high-dose-rate brachytherapy. Brachytherapy. 2021 Nov-Dec; 20(6):1071-1082. PMID: 34588143.
      Citations:    
    13. Boyce-Fappiano D, Nguyen KA, Gjyshi O, Manzar G, Abana CO, Klopp AH, Kamrava M, Orio PF, Thaker NG, Mourtada F, Venkat P, Chang AJ. Socioeconomic and Racial Determinants of Brachytherapy Utilization for Cervical Cancer: Concerns for Widening Disparities. JCO Oncol Pract. 2021 12; 17(12):e1958-e1967. PMID: 34550749.
      Citations:    
    14. King MT, Keyes M, Frank SJ, Crook JM, Butler WM, Rossi PJ, Cox BW, Showalter TN, Mourtada F, Potters L, Stock RG, Kollmeier MA, Zelefsky MJ, Davis BJ, Merrick GS, Orio PF. Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement. Brachytherapy. 2021 Nov-Dec; 20(6):1114-1129. PMID: 34509378.
      Citations:    
    15. Campbell SR, Shah C, Scott JG, Mesko N, Nystrom L, Kolar M, Largo AC, Kamrava M, Mourtada F, Naghavi AO, Harrison LB. American Brachytherapy Society (ABS) consensus statement for soft-tissue sarcoma brachytherapy. Brachytherapy. 2021 Nov-Dec; 20(6):1200-1218. PMID: 34303600.
      Citations:    
    16. Mourtada F, Clement CH, Dauer LT, Baureus Koch C, Cosset JM, Doruff M, Damato A, Guedea F, Scalliet P, Thomadsen B, Pinillos-Ashton L, Small W. Occupational Radiological Protection in Brachytherapy. Ann ICRP. 2021 07; 50(3):5-75. PMID: 34503342.
      Citations:    
    17. Taunk NK, Li T, Petereit DG, Shah C, Mourtada F. In Regard to Dooley et?al. Int J Radiat Oncol Biol Phys. 2021 03 01; 109(3):834-835. PMID: 33516444.
      Citations:    
    18. Frank SJ, Mourtada F, Crook J, Orio PF, Stock RG, Petereit DG, Rossi PJ, Cox BW, Tang C, Kudchadker RJ, Bruno T, Ma J, Sanders J, Keyes M. The American Brachytherapy Society prostate brachytherapy LDR/HDR simulation workshops: Hands-on, step-by-step training in the process of quality assurance. Brachytherapy. 2020 Nov - Dec; 19(6):787-793. PMID: 33132070.
      Citations:    
    19. Thomson RM, Furutani KM, Kaulich TW, Mourtada F, Rivard MJ, Soares CG, Vanneste FM, Melhus CS. AAPM recommendations on medical physics practices for ocular plaque brachytherapy: Report of task group 221. Med Phys. 2020 Jun; 47(5):e92-e124. PMID: 31883269.
      Citations:    
    20. Tom MC, Joshi N, Vicini F, Chang AJ, Hong TS, Showalter TN, Chao ST, Wolden S, Wu AJ, Martin D, Husain Z, Badiyan SN, Kolar M, Sherertz T, Mourtada F, Cohen GN, Shah C. The American Brachytherapy Society consensus statement on intraoperative radiation therapy. Brachytherapy. 2019 May - Jun; 18(3):242-257. PMID: 31084904.
      Citations:    
    21. Siman W, Mikell JK, Mawlawi OR, Mourtada F, Kappadath SC. Dose volume histogram-based optimization of image reconstruction parameters for quantitative 90 Y-PET imaging. Med Phys. 2019 Jan; 46(1):229-237. PMID: 30375655.
      Citations:    
    22. Arnold KM, Flynn NJ, Raben A, Romak L, Yu Y, Dicker AP, Mourtada F, Sims-Mourtada J. The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation Schedules. Cancer Growth Metastasis. 2018; 11:1179064418761639. PMID: 29551910.
      Citations:    
    23. Ma Y, Vijande J, Ballester F, Tedgren ?C, Granero D, Haworth A, Mourtada F, Fonseca GP, Zourari K, Papagiannis P, Rivard MJ, Siebert FA, Sloboda RS, Smith R, Chamberland MJP, Thomson RM, Verhaegen F, Beaulieu L. A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate 192 Ir brachytherapy. Med Phys. 2017 Nov; 44(11):5961-5976. PMID: 28722180.
      Citations:    
    24. Frank SJ, Mourtada F. Bending the slope of the brachytherapy curve: Magnetic resonance imaging-assisted radiosurgery for the treatment of prostate cancer. Brachytherapy. 2017 Jul - Aug; 16(4):657-658. PMID: 28552495.
      Citations:    
    25. Wang J, Tanderup K, Cunha A, Damato AL, Cohen GN, Kudchadker RJ, Mourtada F. Magnetic resonance imaging basics for the prostate brachytherapist. Brachytherapy. 2017 Jul - Aug; 16(4):715-727. PMID: 28396178.
      Citations:    
    26. Jacob D, Lamberto M, DeSouza Lawrence L, Mourtada F. Clinical transition to model-based dose calculation algorithm: A retrospective analysis of high-dose-rate tandem and ring brachytherapy of the cervix. Brachytherapy. 2017 May - Jun; 16(3):624-629. PMID: 28365083.
      Citations:    
    27. Erickson BA, Bittner NH, Chadha M, Mourtada F, Demanes DJ. The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of radionuclide-based high-dose-rate brachytherapy. Brachytherapy. 2017 Jan - Feb; 16(1):75-84. PMID: 28109634.
      Citations:    
    28. Mikell JK, Mahvash A, Siman W, Baladandayuthapani V, Mourtada F, Kappadath SC. Selective Internal Radiation Therapy With Yttrium-90 Glass Microspheres: Biases and Uncertainties in Absorbed Dose Calculations Between Clinical Dosimetry Models. Int J Radiat Oncol Biol Phys. 2016 11 15; 96(4):888-896. PMID: 27623307.
      Citations:    
    29. Quast U, Kaulich TW, ?lvarez-Romero JT, Carlsson Tedgren S, Enger SA, Medich DC, Mourtada F, Perez-Calatayud J, Rivard MJ, Zakaria GA. A brachytherapy photon radiation quality index Q(BT) for probe-type dosimetry. Phys Med. 2016 Jun; 32(6):741-8. PMID: 27237583.
      Citations:    
    30. Mikell J, Cheenu Kappadath S, Wareing T, Erwin WD, Titt U, Mourtada F. Evaluation of a deterministic grid-based Boltzmann solver (GBBS) for voxel-level absorbed dose calculations in nuclear medicine. Phys Med Biol. 2016 06 21; 61(12):4564-82. PMID: 27224727.
      Citations:    
    31. Yu ZH, Kudchadker R, Dong L, Zhang Y, Court LE, Mourtada F, Yock A, Tucker SL, Yang J. Learning anatomy changes from patient populations to create artificial CT images for voxel-level validation of deformable image registration. J Appl Clin Med Phys. 2016 01 08; 17(1):246-258. PMID: 26894362.
      Citations:    
    32. Mikell JK, Mahvash A, Siman W, Mourtada F, Kappadath SC. Comparing voxel-based absorbed dosimetry methods in tumors, liver, lung, and at the liver-lung interface for (90)Y microsphere selective internal radiation therapy. EJNMMI Phys. 2015 Dec; 2(1):16. PMID: 26501817.
      Citations:    
    33. Ballester F, Carlsson Tedgren ?, Granero D, Haworth A, Mourtada F, Fonseca GP, Zourari K, Papagiannis P, Rivard MJ, Siebert FA, Sloboda RS, Smith RL, Thomson RM, Verhaegen F, Vijande J, Ma Y, Beaulieu L. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism. Med Phys. 2015 Jun; 42(6):3048-61. PMID: 26127057.
      Citations:    
    34. Takiar V, Voong KR, Gombos DS, Mourtada F, Rechner LA, Lawyer AA, Morrison WH, Garden AS, Beadle BM. A choice of radionuclide: Comparative outcomes and toxicity of ruthenium-106 and iodine-125 in the definitive treatment of uveal melanoma. Pract Radiat Oncol. 2015 May-Jun; 5(3):e169-e176. PMID: 25423888.
      Citations:    
    35. Melhus CS, Mikell JK, Frank SJ, Mourtada F, Rivard MJ. Dosimetric influence of seed spacers and end-weld thickness for permanent prostate brachytherapy. Brachytherapy. 2014 May-Jun; 13(3):304-10. PMID: 24139289.
      Citations:    
    36. Takiar V, Gombos DS, Mourtada F, Rechner LA, Lawyer AA, Morrison WH, Garden AS, Beadle BM. Disease control and toxicity outcomes using ruthenium eye plaque brachytherapy in the treatment of uveal melanoma. Pract Radiat Oncol. 2014 Jul-Aug; 4(4):e189-94. PMID: 25012839.
      Citations:    
    37. Mikell JK, Klopp AH, Price M, Mourtada F. Commissioning of a grid-based Boltzmann solver for cervical cancer brachytherapy treatment planning with shielded colpostats. Brachytherapy. 2013 Nov-Dec; 12(6):645-53. PMID: 23891341.
      Citations:    
    38. Han T, Followill D, Mikell J, Repchak R, Molineu A, Howell R, Salehpour M, Mourtada F. Dosimetric impact of Acuros XB deterministic radiation transport algorithm for heterogeneous dose calculation in lung cancer. Med Phys. 2013 May; 40(5):051710. PMID: 23635258.
      Citations:    
    39. Sarkar A, Donavanik V, Zhang I, Chen H, Koprowski C, Hanlon A, Mourtada F, Strasser J, Raben A. Prostate implant dosimetric outcomes and migration patterns between bio-absorbable coated and uncoated brachytherapy seeds. Brachytherapy. 2013 Jul-Aug; 12(4):356-61. PMID: 23477885.
      Citations:    
    40. Beaulieu L, Carlsson Tedgren A, Carrier JF, Davis SD, Mourtada F, Rivard MJ, Thomson RM, Verhaegen F, Wareing TA, Williamson JF. Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation. Med Phys. 2012 Oct; 39(10):6208-36. PMID: 23039658.
      Citations:    
    41. Chiu-Tsao ST, Astrahan MA, Finger PT, Followill DS, Meigooni AS, Melhus CS, Mourtada F, Napolitano ME, Nath R, Rivard MJ, Rogers DW, Thomson RM. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS. Med Phys. 2012 Oct; 39(10):6161-84. PMID: 23039655.
      Citations:    
    42. Sims-Mourtada J, Yang D, Tworowska I, Larson R, Smith D, Tsao N, Opdenaker L, Mourtada F, Woodward W. Detection of canonical hedgehog signaling in breast cancer by 131-iodine-labeled derivatives of the sonic hedgehog protein. J Biomed Biotechnol. 2012; 2012:639562. PMID: 22811598.
      Citations:    
    43. Klopp AH, Mourtada F, Yu ZH, Beadle BM, Munsell MF, Jhingran A, Eifel PJ. Pilot study of a computed tomography-compatible shielded intracavitary brachytherapy applicator for treatment of cervical cancer. Pract Radiat Oncol. 2013 Apr-Jun; 3(2):115-23. PMID: 24674314.
      Citations:    
    44. Han T, Mourtada F, Kisling K, Mikell J, Followill D, Howell R. Experimental validation of deterministic Acuros XB algorithm for IMRT and VMAT dose calculations with the Radiological Physics Center's head and neck phantom. Med Phys. 2012 Apr; 39(4):2193-202. PMID: 22482641.
      Citations:    
    45. Mikell JK, Klopp AH, Gonzalez GM, Kisling KD, Price MJ, Berner PA, Eifel PJ, Mourtada F. Impact of heterogeneity-based dose calculation using a deterministic grid-based Boltzmann equation solver for intracavitary brachytherapy. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):e417-22. PMID: 22436788.
      Citations:    
    46. Mourtada F, Mikell J, Ibbott G. Monte Carlo calculations of AAPM Task Group Report No. 43 dosimetry parameters for the (125)I I-Seed AgX100 source model. Brachytherapy. 2012 May-Jun; 11(3):237-44. PMID: 21816684.
      Citations:    
    47. Therriault-Proulx F, Briere TM, Mourtada F, Aubin S, Beddar S, Beaulieu L. A phantom study of an in vivo dosimetry system using plastic scintillation detectors for real-time verification of 192Ir HDR brachytherapy. Med Phys. 2011 May; 38(5):2542-51. PMID: 21776789.
      Citations:    
    48. Han T, Mikell JK, Salehpour M, Mourtada F. Dosimetric comparison of Acuros XB deterministic radiation transport method with Monte Carlo and model-based convolution methods in heterogeneous media. Med Phys. 2011 May; 38(5):2651-64. PMID: 21776802.
      Citations:    
    49. Rivard MJ, Chiu-Tsao ST, Finger PT, Meigooni AS, Melhus CS, Mourtada F, Napolitano ME, Rogers DW, Thomson RM, Nath R. Comparison of dose calculation methods for brachytherapy of intraocular tumors. Med Phys. 2011 Jan; 38(1):306-16. PMID: 21361199.
      Citations:    
    50. Mikell JK, Mourtada F. Dosimetric impact of an 192Ir brachytherapy source cable length modeled using a grid-based Boltzmann transport equation solver. Med Phys. 2010 Sep; 37(9):4733-43. PMID: 20964191.
      Citations:    
    51. Rivard MJ, Beaulieu L, Mourtada F. Enhancements to commissioning techniques and quality assurance of brachytherapy treatment planning systems that use model-based dose calculation algorithms. Med Phys. 2010 Jun; 37(6):2645-58. PMID: 20632576.
      Citations:    
    52. Frank SJ, Tailor RC, Kudchadker RJ, Martirosyan KS, Stafford RJ, Elliott AM, Swanson DA, Sing D, Choi J, Mourtada F, Ibbott GS. Anisotropy characterization of I-125 seed with attached encapsulated cobalt chloride complex contrast agent markers for MRI-based prostate brachytherapy. Med Dosim. 2011; 36(2):200-5. PMID: 20537886.
      Citations:    
    53. Price MJ, Kry SF, Eifel PJ, Salehpour M, Mourtada F. Dose perturbation due to the polysulfone cap surrounding a Fletcher-Williamson colpostat. J Appl Clin Med Phys. 2010 Jan 28; 11(1):3146. PMID: 20160700.
      Citations:    
    54. Vassiliev ON, Wareing TA, McGhee J, Failla G, Salehpour MR, Mourtada F. Validation of a new grid-based Boltzmann equation solver for dose calculation in radiotherapy with photon beams. Phys Med Biol. 2010 Feb 07; 55(3):581-98. PMID: 20057008.
      Citations:    
    55. Gifford KA, Wareing TA, Failla G, Horton JL, Eifel PJ, Mourtada F. Comparison of a 3-D multi-group SN particle transport code with Monte Carlo for intracavitary brachytherapy of the cervix uteri. J Appl Clin Med Phys. 2009 Dec 03; 11(1):3103. PMID: 20160682.
      Citations:    
    56. Price MJ, Jackson EF, Gifford KA, Eifel PJ, Mourtada F. Development of prototype shielded cervical intracavitary brachytherapy applicators compatible with CT and MR imaging. Med Phys. 2009 Dec; 36(12):5515-24. PMID: 20095264.
      Citations:    
    57. Price MJ, Gifford KA, Horton JL, Eifel PJ, Gillin MT, Lawyer AA, Mourtada F. Monte Carlo model for a prototype CT-compatible, anatomically adaptive, shielded intracavitary brachytherapy applicator for the treatment of cervical cancer. Med Phys. 2009 Sep; 36(9):4147-55. PMID: 19810488.
      Citations:    
    58. Kry SF, Price M, Wang Z, Mourtada F, Salehpour M. Investigation into the use of a MOSFET dosimeter as an implantable fiducial marker. J Appl Clin Med Phys. 2009 Jan 27; 10(1):22-32. PMID: 19223838.
      Citations:    
    59. Vassiliev ON, Wareing TA, Davis IM, McGhee J, Barnett D, Horton JL, Gifford K, Failla G, Titt U, Mourtada F. Feasibility of a multigroup deterministic solution method for three-dimensional radiotherapy dose calculations. Int J Radiat Oncol Biol Phys. 2008 Sep 01; 72(1):220-7. PMID: 18722273.
      Citations:    
    60. Gifford KA, Price MJ, Horton JL, Wareing TA, Mourtada F. Optimization of deterministic transport parameters for the calculation of the dose distribution around a high dose-rate 192Ir brachytherapy source. Med Phys. 2008 Jun; 35(6):2279-85. PMID: 18649459.
      Citations:    
    61. Kry SF, Price M, Followill D, Mourtada F, Salehpour M. The use of LiF (TLD-100) as an out-of-field dosimeter. J Appl Clin Med Phys. 2007 Sep 24; 8(4):169-175. PMID: 18449155.
      Citations:    
    62. Mourtada F, Gifford KA, Berner PA, Horton JL, Price MJ, Lawyer AA, Eifel PJ. Retrospective dosimetric comparison of low-dose-rate and pulsed-dose-rate intracavitary brachytherapy using a tandem and mini-ovoids. Med Dosim. 2007; 32(3):181-7. PMID: 17707197.
      Citations:    
    63. Azhdarinia A, Yang DJ, Chao C, Mourtada F. Infrared-based module for the synthesis of 68Ga-labeled radiotracers. Nucl Med Biol. 2007 Jan; 34(1):121-7. PMID: 17210469.
      Citations:    
    64. Beck TJ, Looker AC, Mourtada F, Daphtary MM, Ruff CB. Age trends in femur stresses from a simulated fall on the hip among men and women: evidence of homeostatic adaptation underlying the decline in hip BMD. J Bone Miner Res. 2006 Sep; 21(9):1425-32. PMID: 16939401.
      Citations:    
    65. Kassas B, Mourtada F, Horton JL, Lane RG, Buchholz TA, Strom EA. Dose modification factors for 192Ir high-dose-rate irradiation using Monte Carlo simulation. J Appl Clin Med Phys. 2006 Aug 24; 7(3):28-34. PMID: 17533345.
      Citations:    
    66. Price MJ, Gifford KA, Horton J, Lawyer A, Eifel P, Mourtada F. Comparison of dose distributions around the pulsed-dose-rate Fletcher-Williamson and the low-dose-rate Fletcher-Suit-Delclos ovoids: a Monte Carlo study. Phys Med Biol. 2006 Aug 21; 51(16):4083-94. PMID: 16885626.
      Citations:    
    67. Apisarnthanarax S, Alauddin MM, Mourtada F, Ariga H, Raju U, Mawlawi O, Han D, Bornmann WG, Ajani JA, Milas L, Gelovani JG, Chao KS. Early detection of chemoradioresponse in esophageal carcinoma by 3'-deoxy-3'-3H-fluorothymidine using preclinical tumor models. Clin Cancer Res. 2006 Aug 01; 12(15):4590-7. PMID: 16899606.
      Citations:    
    68. Gifford KA, Horton JL, Wareing TA, Failla G, Mourtada F. Comparison of a finite-element multigroup discrete-ordinates code with Monte Carlo for radiotherapy calculations. Phys Med Biol. 2006 May 07; 51(9):2253-65. PMID: 16625040.
      Citations:    
    69. Price MJ, Horton JL, Gifford KA, Eifel PJ, Jhingran A, Lawyer AA, Berner PA, Mourtada F. Dosimetric evaluation of the Fletcher-Williamson ovoid for pulsed-dose-rate brachytherapy: a Monte Carlo study. Phys Med Biol. 2005 Nov 07; 50(21):5075-87. PMID: 16237242.
      Citations:    
    70. Gifford KA, Mourtada F, Cho SH, Lawyer A, Horton JL. Monte Carlo calculations of the dose distribution around a commercial gynecologic tandem applicator. Radiother Oncol. 2005 Nov; 77(2):210-5. PMID: 16216363.
      Citations:    
    71. Gifford KA, Horton JL, Pelloski CE, Jhingran A, Court LE, Mourtada F, Eifel PJ. A three-dimensional computed tomography-assisted Monte Carlo evaluation of ovoid shielding on the dose to the bladder and rectum in intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2005 Oct 01; 63(2):615-21. PMID: 16168853.
      Citations:    
    72. Gifford KA, Horton JL, Jackson EF, Steger TR, Heard MP, Mourtada F, Lawyer AA, Ibbott GS. Comparison of Monte Carlo calculations around a Fletcher Suit Delclos ovoid with radiochromic film and normoxic polymer gel dosimetry. Med Phys. 2005 Jul; 32(7Part1):2288-2294. PMID: 28493569.
      Citations:    
    73. Gifford KA, Horton JL, Jackson EF, Steger TR, Heard MP, Mourtada F, Lawyer AA, Ibbott GS. Comparison of Monte Carlo calculations around a Fletcher Suit Delclos ovoid with radiochromic film and normoxic polymer gel dosimetry. Med Phys. 2005 Jul; 32(7):2288-94. PMID: 16121584.
      Citations:    
    74. Beddar AS, Briere TM, Mourtada FA, Vassiliev ON, Liu HH, Mohan R. Monte Carlo calculations of the absorbed dose and energy dependence of plastic scintillators. Med Phys. 2005 May; 32(5):1265-9. PMID: 15984678.
      Citations:    
    75. Mourtada F, Horton JL. Dose perturbation of a novel cobalt chromium coronary stent on 32P intravascular brachytherapy: a monte carlo study. Med Phys. 2005 Jan; 32(1):268-74. PMID: 15719978.
      Citations:    
    76. Kassas B, Mourtada F, Horton JL, Lane RG. Contrast effects on dosimetry of a partial breast irradiation system. Med Phys. 2004 Jul; 31(7):1976-9. PMID: 15305449.
      Citations:    
    77. Mourtada F, Soares CG, Horton JL. A segmented 32P source Monte Carlo model to derive AAPM TG-60 dosimetric parameters used for intravascular brachytherapy. Med Phys. 2004 Mar; 31(3):602-8. PMID: 15070260.
      Citations:    
    78. Mourtada F, Soares CG, Seltzer SM, Bergstrom PM, Fern?ndez-Verea JM, Asenjo J, Lott SH. Dosimetry characterization of a 32P source wire used for intravascular brachytherapy with automated stepping. Med Phys. 2003 May; 30(5):959-71. PMID: 12773005.
      Citations:    
    79. Kaluza GL, Jenkins TP, Mourtada FA, Ali NM, Lee DP, Okura H, Fitzgerald PJ, Raizner AE. Targeting the adventitia with intracoronary beta-radiation: comparison of two dose prescriptions and the role of centering coronary arteries. Int J Radiat Oncol Biol Phys. 2002 Jan 01; 52(1):184-91. PMID: 11777637.
      Citations:    
    Mourtada's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (235)
    Explore
    _
    Co-Authors (2)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _